Evaluation of NxTek™ Eliminate Malaria-PF test and biocredit rapid diagnostic tests for detecting Plasmodium species in Southern Ethiopia

对埃塞俄比亚南部地区 NxTek™ Eliminate Malaria-PF 检测和生物信用快速诊断检测疟原虫种类的评估

阅读:1

Abstract

BACKGROUND: Rapid diagnostic tests (RDTs) play an essential role in the prompt diagnosis of malaria in settings where using microscopy is not feasible. This study aimed to evaluate the diagnostic performance of NxTek™ Eliminate Malaria-Pf test, Biocredit RDTs Pf(pLDH/HRP2) and Pf/Pv(pLDH/pLDH) for the detection of Plasmodium species. METHODS: A health facility-based cross-sectional study was conducted from September to November 2024 in 384 malaria-suspected febrile study subjects at Dilla Zuria health facility. Venous blood samples were collected for malaria diagnosis using microscopy, RDTs, and quantitative Polymerase Chain Reaction (qPCR). Sensitivity, specificity, positive/negative predictive value, and accuracy were calculated using microscopy and qPCR as reference standards. RESULTS: Using microscopy as the reference standard, the NxTek™ Eliminate Malaria-Pf test demonstrated a sensitivity of 87.6% and a specificity of 91.3% for the detection of P. falciparum. The Biocredit Pf/Pv (pLDH/pLDH) RDT exhibited a sensitivity of 97.9% and specificity of 97.4% for P. falciparum, and a sensitivity of 94.5% and specificity of 97.5% for P. vivax. The Biocredit Pf (pLDH/HRP2) RDT showed sensitivity and specificity values of 97.4% and 97.5%, respectively. In comparison, the SD Bioline RDT yielded a sensitivity of 51.3% and specificity of 93.2% for P. falciparum, and sensitivity and specificity of 86.3% and 96.5%, respectively, for P. vivax. When using quantitative PCR (qPCR) as the reference standard, the Biocredit Pf/Pv (pLDH/pLDH) RDT demonstrated a sensitivity of 95.5% and specificity of 96.4% for P. falciparum, and sensitivity and specificity of 90.8% and 99.1%, respectively, for P. vivax. CONCLUSION: The Biocredit RDTs outperformed conventional RDTs in both sensitivity and specificity and met the World Health Organization’s (WHO) diagnostic criteria. These results support their utility in routine malaria diagnosis, particularly in resource-limited endemic settings. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12879-026-13038-7.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。